Volume | 1 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Hologic Inc | HOLX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
76.35 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
1 | 1 | - | 64.02 - 87.88 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
08:01:08 | 1 | $ 76.35 | USD |
Hologic (HOLX) Options Flow Summary
Hologic Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
17.92B | 234.73M | - | 4.05B | 456M | 1.94 | 39.30 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Hologic News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HOLX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 75.98 | 76.81 | 74.47 | 75.91 | 2,324,142 | 0.37 | 0.49% |
1 Month | 73.69 | 77.14 | 73.05 | 75.38 | 1,758,154 | 2.66 | 3.61% |
3 Months | 71.07 | 77.14 | 70.53 | 73.90 | 1,833,299 | 5.28 | 7.43% |
6 Months | 71.83 | 77.14 | 64.02 | 71.57 | 1,848,184 | 4.52 | 6.29% |
1 Year | 77.27 | 87.88 | 64.02 | 74.96 | 1,703,719 | -0.92 | -1.19% |
3 Years | 71.22 | 87.88 | 59.78 | 73.08 | 1,756,689 | 5.13 | 7.20% |
5 Years | 47.27 | 87.88 | 26.49 | 65.05 | 1,899,457 | 29.08 | 61.52% |
Hologic Description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |